PRAX vs. SMH

In the year-to-date period, PRAX achieves a -50.04% return, which is significantly lower than SMH's 0.79% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Praxis Precision Medicines, Inc. (PRAX) and VanEck Vectors Semiconductor ETF (SMH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current PRAX Sharpe Ratio is -0.21, which is lower than the SMH Sharpe Ratio of -0.00. The chart below compares the historical Sharpe Ratios of PRAX and SMH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

PRAX has not paid dividends to shareholders, while SMH's dividend yield for the trailing twelve months is around 0.44%.

The maximum PRAX drawdown since its inception was -98.66%, which is greater than SMH's maximum drawdown of -83.29%. Use the drawdown chart below to compare losses from any high point for PRAX and SMH.

Praxis Precision Medicines, Inc. (PRAX) has a higher volatility of 18.61% compared to VanEck Vectors Semiconductor ETF (SMH) at 8.70%. This indicates that PRAX's price experiences larger fluctuations and is considered to be riskier than SMH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.